#oral medication

All articles tagged with "oral medication"

Structure Therapeutics reports more Phase 2 data for oral GLP-1

Oral GLP-1 Drug Shows Promise in New Phase 2 Trial Data

Structure Therapeutics reports encouraging Phase 2 results for its oral GLP-1 receptor agonist, advancing a pill-form alternative to injectable weight-loss and diabetes drugs.

Key Takeaways

Structure Therapeutics reports Phase 2 data showing GSBR-1290 produces meaningful weight reduction in obesity patients
Small-molecule design approach aims to improve oral bioavailability over peptide-based GLP-1 drugs

DT Editorial Team·Mar 16, 2026·5 min read·via endpoints.news

GLP-1 Weight Loss Pills Arrive, Ushering In a New Era of Obesity Treatment

After years of development challenges, oral GLP-1 weight loss drugs are finally hitting the market. Novo Nordisk's oral Wegovy is already available, with Eli Lilly's orforglipron expected to win FDA approval soon.

Key Takeaways

Novo Nordisk's oral Wegovy is now available, with Lilly's orforglipron approval expected soon
Creating oral GLP-1 drugs required solving major absorption challenges with peptide molecules

DT Editorial Team·Mar 8, 2026·3 min read·via statnews.com

Novo Nordisk Partners With MIT-Backed Startup to Develop Oral Obesity Drugs

Novo Nordisk has struck a deal with Vivtex, a biotech co-founded by MIT professor Robert Langer, to develop oral versions of obesity and diabetes treatments. The partnership could eliminate the need for weekly injections that have defined the GLP-1 drug revolution.

Key Takeaways

Novo Nordisk deals with Vivtex to develop oral alternatives to injectable obesity and diabetes drugs
Vivtex was co-founded by MIT's Robert Langer, also a Moderna co-founder

DT Editorial Team·Feb 25, 2026·4 min read·via statnews.com